Form 4: USANA Health Sciences Inc: Chief Scientific Officer Robert A. Sinnott Reports Stock Sale

Robert A. Sinnott, Chief Scientific Officer of USANA Health Sciences Inc, reported the sale of 3,945 shares of common stock on March 5, 2024.

Summary

• On March 5, 2024, Robert A. Sinnott, the Chief Scientific Officer of USANA Health Sciences Inc, sold 3,945 shares of the company's common stock.
• The sale was executed at a weighted average price of $46.555 per share.
• The price range for the multiple transactions was between $46.4801 and $46.65 inclusively.
• Following the reported transaction, Sinnott directly owns 0 shares of USANA Health Sciences Inc.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a stock sale. The sentiment is neither positive nor negative as it simply reports a transaction.

Industry Context

This is a routine disclosure of an insider transaction. It's important to monitor insider transactions as they can sometimes provide insights into management's perspective on the company's future prospects, although this single transaction is unlikely to be indicative of a larger trend.

Stakeholder Impact

• The sale of shares by a high-ranking officer could be perceived negatively by shareholders, although the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates